Key players operating in the Sphygmomanometer Market are Omron Healthcare, ICU
Medical Inc., Koninklijke Philips N.V., Baxter, Nihon Kohden, AD Medical,
Spengler, SunTech Medical, Rudolf Riester GmbH, Microlife Corporation, American
Diagnostic Corporation, Panasonic Healthcare, Beurer, Rossmax International
Ltd., PAUL HARTMANN, BPL Medical Technologies, Homedics.
Key Takeaways:
Key players: Omron Healthcare is a leading player in sphygmomanometer market
with strong distribution network globally. It offers range of affordable and
accurate blood pressure monitoring devices for hospitals as well as homecare
segment. The market is witnessing rising prominence of private label brands
from players such as Microlife and Panasonic Healthcare.
Growing demand:
Sphygmomanometer
Market Size Growing prevalence of hypertension and cardiovascular
diseases has increased the adoption of sphygmomanometers globally. However,
demand is higher from developed markets where awareness about hypertension
self-monitoring is well established. Homecare blood pressure monitors segment
is growing at fastest pace.
Technological advancement: Recent technological advancements are focused on
integrating smartphone connectivity and wireless data transmission capabilities
in sphygmomanometers for telehealth and remote patient monitoring. Portable,
wearable and automated cuffless blood pressure monitors are new genres emerging
with improved accuracy.
Market Trends:
- Increased preference for wireless, portable and wearable blood pressure
monitors for self-monitoring at home as well as remote patient monitoring.
- Growing popularity of automatic inflating cuff technology reducing human
error in measurement.
- Integration of blood pressure monitoring devices with EHR and telemedicine
platforms for centralized monitoring of patients.
Market Opportunities:
- Untapped opportunities exist in developing Asian and African markets with
increasing healthcare spending.
- Growing geriatric population prone to hypertension presents an opportunity
for targeted product development.
- Development of affordable, smartphone-compatible devices for self-monitoring
presents a significant opportunity.
Impact of COVID-19 on Sphygmomanometer Market Growth
The COVID-19 pandemic has significantly impacted the growth of the
sphygmomanometer market. During the outbreak, demand for blood pressure
monitoring devices surged globally as monitoring blood pressure was critical
for detecting COVID-19 symptoms and managing patients. However, supply chain
disruptions caused by lockdowns and trade restrictions adversely affected the
production and distribution of sphygmomanometers. This led to shortages of devices
in the initial months of the pandemic.
As the pandemic progressed, governments and healthcare organizations
prioritized increasing domestic production of sphygmomanometers to meet the
growing demand. Major players also focused on ramping up manufacturing while
ensuring safety protocols. Remote patient monitoring also gained prominence
during this time due to social distancing norms. This boosted demand for
portable, Bluetooth-enabled home-use sphygmomanometers allowing self-monitoring
and transmission of readings to doctors online. Telehealth emerged as an
important avenue for blood pressure checks.
Going forward, demand for personal use devices is expected to remain high even
post-pandemic. This is attributed to increased health awareness among the masses
and growing preference for self-monitoring. However, returns or replacements
may decline due to budget constraints caused by the economic crisis triggered
by the pandemic. The market will continue prioritizing affordability and
precision to expand access in the emerging regions severely impacted by
COVID-19.
Europe currently generates the highest revenue in the sphygmomanometer market
due to sophisticated healthcare infrastructure and growing incidence of
hypertension. However, Asia Pacific is slated to be the fastest-growing
regional market in the coming years. The massive patient pool, rising
healthcare expenditure, and rapid infrastructure development in countries like
China and India offer immense opportunities. Moreover, increasing awareness regarding
benefits of regular monitoring and availability of low-cost devices are
propelling adoption.
Comments
Post a Comment